PhaseRx Inc (PZRXQ)
0.0002
0.00 (0.00%)
USD |
OTCM |
Apr 16, 16:00
PhaseRx Cash from Investing (TTM): 9.97M for Sept. 30, 2017
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2017 | 9.97M |
June 30, 2017 | 2.545M |
March 31, 2017 | -5.191M |
December 31, 2016 | -5.664M |
Date | Value |
---|---|
September 30, 2016 | -10.24M |
June 30, 2016 | -6.24M |
March 31, 2016 | -0.256M |
December 31, 2015 | -0.114M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
FluoroPharma Medical Inc | -0.0013M |
RenovaCare Inc | -- |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | -0.0071M |
OncoVista Innovative Therapies Inc | 0.00 |